Hypertension in dialysis and kidney transplant patients
AUTOR(ES)
Prasad, GV Ramesh
FONTE
Pulsus Group Inc
RESUMO
For the first time, the Canadian Hypertension Education Program has studied the evidence supporting blood pressure control in people requiring renal replacement therapy for end-stage kidney disease, including those on dialysis and with renal transplants. According to the Canadian Organ Replacement Registry’s 2008 annual report, there were an estimated 33,832 people with end-stage renal disease in Canada at the end of 2006, an increase of 69.7% since 1997. Of these, 20,465 were on dialysis and 13,367 were living with a functioning kidney transplant. Thus, it is becoming more likely that primary care practitioners will be helping to care for these complex patients. With the lack of large controlled clinical trials, the consensus recommendation based on interpretation of the existing literature is that blood pressure should be lowered to below 140/90 mmHg in hypertensive patients on renal replacement therapy and to below 130/80 mmHg for renal transplant patients with diabetes or chronic kidney disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2707167Documentos Relacionados
- Cross-transmission of vancomycin-resistant Enterococcus in patients undergoing dialysis and kidney transplant
- GB virus C/hepatitis G virus infection in dialysis patients and kidney transplant recipients in central Brazil
- Torque teno virus among dialysis and renal-transplant patients
- Influence of dialysis duration and parathyroid hormone on the clinical and radiographic oral conditions of pre-transplant patients with chronic kidney disease
- Cholelithiasis in patients on the kidney transplant waiting list
